Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ).
Jubilant Pharmova Limited has issued a second communication to its shareholders regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF). This move is in compliance with the Companies Act, 2013, and the IEPF Rules, which mandate the transfer of shares for which dividends have not been claimed for seven consecutive years. The company has reminded shareholders that unclaimed dividends from the financial year 2017-18 are due for transfer to the IEPF by November 1, 2025, unless there are specific legal restrictions. This action ensures compliance with regulatory requirements and affects shareholders who have not claimed their dividends, potentially impacting their equity holdings.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its contributions to healthcare through innovative solutions and its market focus on both domestic and international sectors.
Average Trading Volume: 11,372
Technical Sentiment Signal: Buy
Current Market Cap: 177.3B INR
Find detailed analytics on JUBLPHARMA stock on TipRanks’ Stock Analysis page.